RxDoctor Payments Data

Alissa Bell, APRN

Family · Campton, KYNPI 1962630475

Payments from drug & device makers

$2,325in general payments, 2019–2025

Across 141 payments — averaging $16.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$614
  • Boehringer Ingelheim$426
  • AbbVie$355
  • Amgen$149
  • Novo Nordisk$120
  • Pfizer$115
  • plus $545 from 11 others

What the payments were for

  • Food & beverage$2,325100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,325 in reported general payments places this provider in the 80th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$569
Medicare patients
15
Services billed
22

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin83$94,804
OzempicSemaglutide69$84,321
Trelegy ElliptaFluticasone/Umeclidin/Vilanter55$49,505
MounjaroTirzepatide25$40,491
EliquisApixaban41$34,033
JanuviaSitagliptin Phosphate39$31,709
TrulicityDulaglutide22$27,966
FarxigaDapagliflozin Propanediol37$22,633
LinzessLinaclotide24$22,446
Breztri AerosphereBudesonide/Glycopyr/Formoterol26$20,081
TradjentaLinagliptin21$19,889
Tresiba Flextouch U-200Insulin Degludec18$19,457
RexultiBrexpiprazole11$17,355
XareltoRivaroxaban15$16,889
Aripiprazole11$12,681

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$426$114,693104 claims
Novo NordiskOzempic$120$84,32169 claims
Lilly USA, LLCMounjaro, Trulicity$11$68,45747 claims
AstraZenecaFarxiga, Breztri Aerosphere, Brilinta, Symbicort$72$56,946100 claims
GSKTrelegy Ellipta$614$49,50555 claims
PfizerEliquis$115$34,03341 claims
AbbVieLinzess, Ubrelvy$355$33,61735 claims
MerckJanuvia$84$31,70939 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,374 family providers in Kentucky.

Other family in Campton

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →